Compartir
Título
Effects of aging and cyclosporin treatment on the hepatobiliary efflux of glutathione
Autor(es)
Palabras clave
Envejecimiento
Tratamiento
Free radicals
Liver glutathione
Cyclosporin A
Biliary glutathione
Aging
Clasificación UNESCO
3209 Farmacología
6310.03 Enfermedad
Fecha de publicación
2003
Editor
Elsevier
Citación
Palomero, J., Galán, A., Muñoz, M., Tuñon, M., González Gallego, J., Jiménez, R. (2003). Effects of aging and cyclosporin treatment on the hepatobiliary efflux of glutathione. Life Sciences, 73 (26) pp 3387-3397. 10.1016/J.LFS.2003.06.019
Resumen
[EN] The aim of this study was to investigate the effects of cyclosporin (CyA) treatment on biliary glutathione efflux
in rats of different ages (1, 2, 4, and 24 months). CyA treatment reduced the liver content of total glutathione in 1-,
2- and 24 month old rats ( 30%, 43% and 30%, respectively). By contrast, oxidized glutathione (GSSG)
concentration in liver tended to increase, although non significantly, in the rats aged 4 and 24 month ( + 36% and
+ 28%, respectively). The oxidized-to-reduced glutathione ratio was significantly increased in 2-, 4- and 24 month
old animals ( + 23%, + 36% and >100%, respectively). Regarding biliary glutathione, our data indicate that efflux
rates of total glutathione in control (untreated) rats increased to a maximum at 4 months, and decreased ( 56%) in
24 month old rats, although values were still higher than those from young animals. CyA treatment significantly
reduced biliary glutathione secretion except in 24 month old rats ( 98%, 66% and 32%, at 1, 2 and 4 month,
respectively). In addition, following inhibition of the intrabiliary catabolism of the tripeptide by acivicin,
glutathione efflux rates into bile were significantly reduced by the drug only in 1- and 2 month old rats ( 29%
and 55%, respectively) and even tended to increase, although non significantly, in oldest animals. Our data
indicate that inhibition of biliary glutathione efflux by CyA was greater in younger rats and support the view that
increased intrabiliary catabolism of the tripeptide and inhibition of its canalicular transport could contribute to the
decline in biliary glutathione secretion induced by the drug.
URI
ISSN
0024-3205
DOI
10.1016/J.LFS.2003.06.019
Versión del editor
Aparece en las colecciones













